Suppr超能文献

四名 1 型糖尿病患者安全完赛超长距离越野跑。

Safe Completion of a Trail Running Ultramarathon by Four Men with Type 1 Diabetes.

机构信息

1 Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences , Poznan, Poland .

2 Department of Metabolic Diseases, Jagiellonian University Medical College , Kraków, Poland .

出版信息

Diabetes Technol Ther. 2018 Feb;20(2):147-152. doi: 10.1089/dia.2017.0296. Epub 2018 Jan 2.

Abstract

In this brief report, we describe the feat of four men with type 1 diabetes mellitus (T1DM) who decided to take part in a mountain ultramarathon in Bieszczady, Poland on May 27, 2016. Before participating in the competition, they asked two diabetologists for a consultation and to assist in diabetic control during the marathon. The aim of the study was to assess the metabolic safety in people with T1DM during extreme physical exertion in a mountain ultramarathon. All subjects were treated with continuous subcutaneous insulin infusion. The marathon route was 82 km, and the sum of the climbs and descents was 3235 and 3055 m, respectively. Diabetologists controlled glucose levels using a glucometer, plasma lactate levels, and ketones in the capillary blood. In addition, they monitored the intake of carbohydrates and fluids. Clinical tests were performed at the three checkpoints (at 32, 49, and 66 km) during the race and after completing the race (at 82 km). This study shows that extreme physical exertion by a person with type 1 diabetes is possible. All subjects avoided severe hypoglycemia by significantly reducing their insulin dose and consuming additional carbohydrates. Such actions, despite the occurrence of hyperglycemia >250 mg/dL did not result in ketoacidosis. Safe participation in mountain ultramarathons by people with type 1 diabetes can be achieved if they undertake appropriate physical and diabetologic preparation.

摘要

在这份简短的报告中,我们描述了四位 1 型糖尿病患者(T1DM)的壮举,他们决定于 2016 年 5 月 27 日参加在波兰比斯卡日采举行的山地超级马拉松赛。参赛前,他们咨询了两位糖尿病专家,以协助他们在马拉松比赛期间控制血糖。该研究旨在评估 T1DM 患者在山地超级马拉松比赛中极端体力活动下的代谢安全性。所有受试者均接受持续皮下胰岛素输注治疗。马拉松赛的路线长 82 公里,累计爬升和下降分别为 3235 米和 3055 米。糖尿病专家使用血糖仪、血浆乳酸水平和毛细血管血酮来控制血糖水平。此外,他们还监测碳水化合物和液体的摄入。在比赛期间的三个检查点(32 公里、49 公里和 66 公里)和比赛结束后(82 公里)进行临床检查。本研究表明,1 型糖尿病患者进行极端体力活动是可行的。所有受试者通过显著减少胰岛素剂量和摄入额外的碳水化合物来避免严重低血糖。尽管出现了 >250mg/dL 的高血糖,但这些措施并未导致酮症酸中毒。如果 1 型糖尿病患者进行适当的身体和糖尿病准备,他们可以安全地参加山地超级马拉松比赛。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验